Freeport-McMoran (FCX) Misses Q1 EPS by 16c, Revenues Miss; Provides Revised Operating Plan
Get Alerts FCX Hot Sheet
Price: $72.73 --0%
EPS Growth %: +44.0%
Financial Fact:
Exploration and research expenses: 13M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +44.0%
Financial Fact:
Exploration and research expenses: 13M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Freeport-McMoran (NYSE: FCX) reported Q1 EPS of ($0.34), $0.16 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $2.8 billion versus the consensus estimate of $2.9 billion.
For earnings history and earnings-related data on Freeport-McMoran (FCX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Freedom Broker Upgrades Freeport-McMoRan (FCX) to Buy
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share